Lumos Diagnostics (ASX: LDX), known for its rapid point-of-care (POC) diagnostics tests, has expanded its partnership with Henry Schein Medical…
A recent report revealed that, in the US, the rate of babies being born prematurely has been rising. Between 2014…
Diagnostic tech company Lumos Diagnostics (ASX: LDX) has received the green card from the US Food and Drug Administration (FDA)…
One of the punching bags of the ASX, Lumos Diagnostics (ASX: LDX), which develops diagnostics for healthcare professionals to more…
Cash, it's the lifeblood of any business and while their specialty in early stage disease diagnosis, Lumos Diagnostics (ASX: LDX)…
While small cap shareholders have become accustomed to major share price gains once a medtech or biotech receives FDA approval…